AccuStem Sciences, Inc.
ACUT
$0.4512
$0.00020.04%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 45.16% | 25.38% | 36.81% | 74.86% | 33.43% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -5.53% | 10.32% | -30.53% | -51.82% | -47.63% |
| Change in Net Operating Assets | -59.97% | 133.11% | -24.97% | -122.22% | -25.84% |
| Cash from Operations | 38.03% | 59.99% | 46.78% | 52.60% | 36.68% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -42.24% | -50.25% | -- | 616.19% | 8,468.09% |
| Total Debt Repaid | 76.59% | 71.07% | 48.09% | -172.49% | 6.06% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -30.79% | -46.88% | 309.88% | 910.29% | 420.25% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 81.85% | 161.17% | 97.81% | 91.72% | 92.36% |
